DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) has earned an average rating of “Hold” from the thirteen brokerages that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $92.45.
Several research firms have recently issued reports on DOCU. UBS Group lifted their price target on DocuSign from $60.00 to $100.00 and gave the stock a “neutral” rating in a research note on Friday, December 6th. Royal Bank of Canada restated a “sector perform” rating and set a $90.00 target price (up previously from $57.00) on shares of DocuSign in a research report on Friday, December 6th. Robert W. Baird increased their price target on shares of DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of DocuSign in a research report on Friday, December 6th. Finally, Citigroup increased their target price on DocuSign from $87.00 to $113.00 and gave the company a “buy” rating in a report on Friday, December 6th.
View Our Latest Research Report on DOCU
DocuSign Stock Performance
Insider Activity at DocuSign
In related news, CFO Blake Jeffrey Grayson sold 15,588 shares of the stock in a transaction on Wednesday, December 18th. The stock was sold at an average price of $97.78, for a total value of $1,524,194.64. Following the transaction, the chief financial officer now directly owns 85,851 shares of the company’s stock, valued at approximately $8,394,510.78. This trade represents a 15.37 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Allan C. Thygesen sold 7,764 shares of DocuSign stock in a transaction on Friday, November 1st. The shares were sold at an average price of $69.95, for a total value of $543,091.80. Following the completion of the transaction, the chief executive officer now owns 107,825 shares in the company, valued at $7,542,358.75. The trade was a 6.72 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 693,089 shares of company stock worth $66,320,395. 1.66% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of DOCU. Thrivent Financial for Lutherans purchased a new stake in DocuSign during the second quarter worth approximately $115,795,000. Pacer Advisors Inc. boosted its position in DocuSign by 77.9% during the 2nd quarter. Pacer Advisors Inc. now owns 3,519,969 shares of the company’s stock worth $188,318,000 after purchasing an additional 1,541,816 shares during the period. KBC Group NV increased its holdings in DocuSign by 209.8% in the 3rd quarter. KBC Group NV now owns 1,156,874 shares of the company’s stock valued at $71,830,000 after purchasing an additional 783,419 shares in the last quarter. Renaissance Technologies LLC increased its holdings in DocuSign by 18.3% in the 2nd quarter. Renaissance Technologies LLC now owns 3,729,314 shares of the company’s stock valued at $199,518,000 after purchasing an additional 576,414 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ raised its position in DocuSign by 151.3% in the second quarter. Skandinaviska Enskilda Banken AB publ now owns 865,872 shares of the company’s stock valued at $46,324,000 after purchasing an additional 521,292 shares during the period. Hedge funds and other institutional investors own 77.64% of the company’s stock.
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
- Five stocks we like better than DocuSign
- What Does Downgrade Mean in Investing?
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Golden Cross Stocks: Pattern, Examples and Charts
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- High Flyers: 3 Natural Gas Stocks for March 2022
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.